Why Hair Loss Happens

Most men who experience progressive thinning have androgenetic alopecia, also called male pattern hair loss. In genetically predisposed individuals, the hormone dihydrotestosterone (DHT) binds to receptors in scalp hair follicles. Over time this shortens the growth (anagen) phase and causes follicles to shrink, producing finer, shorter hairs until they stop producing visible hair. The enzyme 5-alpha reductase converts testosterone into DHT. Targeting this pathway or improving blood flow to the follicles forms the basis of most effective medical treatments.

The Appeal and Limitations of Overseas Hair Transplants

Many men consider traveling to countries such as Turkey for hair transplant packages that appear far less expensive than procedures performed in the United States. These packages often include surgery, hotel, and airport transfers. High-volume clinics perform thousands of cases yearly, and some reputable centers achieve good graft survival.

However, the industry has well-documented problems. Regulatory gaps allow unlicensed technicians to perform critical parts of the procedure in some clinics. Reports from the International Society of Hair Restoration Surgery and medical associations describe botched hairlines, over-harvesting of donor areas, infections, scarring, and tissue necrosis. Follow-up care is limited once the patient returns home, and corrective surgery—if needed—often costs more than the original package. For most men, the combination of variable quality, limited accountability, and logistical challenges makes overseas surgery a higher-risk choice than carefully managed medical options available locally.

Medical Options That Address the Biology of Hair Loss

Minoxidil

Minoxidil was originally developed as a blood-pressure medication. When applied to the scalp it acts as a potassium-channel opener and mild vasodilator. This increases blood flow around the follicle and appears to prolong the anagen phase while shortening the resting (telogen) phase. Clinical trials show that 5% topical minoxidil produces measurable increases in hair count compared with placebo. Results typically become noticeable after 3–6 months of consistent use and require ongoing application to maintain gains. Topical forms (solution or foam) are applied to a dry scalp after showering. Low-dose oral minoxidil is also used off-label and can be more convenient for some men.

Finasteride

Finasteride inhibits the type II isoform of 5-alpha reductase, reducing conversion of testosterone to DHT. Lower scalp DHT levels slow follicle miniaturization. Oral finasteride 1 mg daily has been shown in large randomized trials to increase hair count and prevent further loss in a substantial proportion of men. Topical formulations are also available and may reduce systemic exposure for men concerned about side effects. Sexual side effects occur in a minority of users and often resolve with dose adjustment or discontinuation. Regular monitoring and discussion of risks with a clinician remain important.

Biotin (Vitamin B-9)

Biotin is a B-vitamin involved in keratin production. Clear evidence of benefit is strongest in people with true biotin deficiency; in otherwise healthy men the effect is modest. Still, many multi-ingredient formulas include biotin because it is low-risk and may support overall hair structure when combined with proven agents.

Application Methods

Topical serums or solutions are typically applied once or twice daily to clean, dry scalp after showering and left in place. Oral capsules offer simplicity and consistent systemic delivery. Combination products that include both minoxidil and finasteride (with or without biotin) target multiple pathways at once—improving local blood flow while lowering DHT and supporting keratin structure.

Integrating Hair Treatment With Broader Hormone Care

Because DHT is derived from testosterone, men already addressing hormone balance may benefit from coordinated evaluation. Providers who review full hormone panels alongside hair concerns can help determine whether adjustments in testosterone management or supportive therapies are warranted. Services available through Vita Bella offer clinician-guided hormone and peptide programs that can be paired with hair-focused strategies when appropriate.

One practical multi-pathway option is the Oral Cedar Hair product used by Vita Bella, which combines minoxidil, finasteride, and biotin. This formulation simultaneously addresses blood flow to the follicle, DHT reduction, and structural support—three complementary mechanisms. Men seeking supervised access to such combinations, along with laboratory monitoring, can explore these through Vita Bella.

Putting It Together

For most men, consistent medical treatment with minoxidil and/or finasteride, possibly combined with biotin, offers a lower-risk and more controllable path than high-volume overseas surgery. Results require patience and ongoing use. Working with a clinician who can monitor progress, manage side effects, and integrate hair care with overall hormone status improves the chance of meaningful, sustainable improvement.

References

1. International Society of Hair Restoration Surgery. Buyer beware: medical tourism for hair transplants can have costly consequences. ISHRS; 2016. Available from: https://ishrs.org/buyer-beware-medical-tourism-for-hair-transplants-can-have-costly-consequences/

2. Haider SA, et al. The allures and the alarms of the hair transplant tourism industry: a critical review with Turkey as a case study. [PubMed abstract]. 2025.

3. Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786. doi:10.2147/DDDT.S214907

4. Patel P, Nessel TA, Kumar DD. Minoxidil. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

5. Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Minoxidil: a comprehensive review. J Dermatolog Treat. 2022;33(4):1896-1906. doi:10.1080/09546634.2021.1945527

6. Zito PM, Bistas KG, Syed K. Finasteride. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

7. Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investig Dermatol Symp Proc. 2003;8(1):20-23. doi:10.1046/j.1523-1747.2003.12181.x

8. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Finasteride for hair loss: a review. J Dermatolog Treat. 2022;33(4):1938-1946. doi:10.1080/09546634.2021.1959506

9. Piraccini BM, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. doi:10.1111/jdv.17738